Since Flt3Lg stimulates proliferation in AML (as we demonstrate by using an in vitro model), disruption of the Flt3Lg binding site in Flt3 may deprive blast cells of the proliferative advantage. Here, FLT3 is linked to acute myeloid leukemia.